References
Law BZY, Yusuf Z, Ng YE, Aly EH (2020) Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer? Int J Colorectal Dis
Nakamura T, Watanabe M (2013) Lateral lymph node dissection for lower rectal cancer. World J Surg 37(8):1808–1813
Malakorn S, Yang Y, Bednarski BK, Kaur H, You YN, Holliday EB, Dasari A, Skibber JM, Rodriguez-Bigas MA, Chang GJ (2019) Who should get lateral pelvic lymph node dissection after neoadjuvant chemoradiation? Dis Colon Rectum 62(10):1158–1166
Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, Ohue M, Ota M, Akazai Y, Shiozawa M, Yamaguchi T, Bandou H, Katsumata K, Murata K, Akagi Y, Takiguchi N, Saida Y, Nakamura K, Fukuda H, Akasu T, Moriya Y (2017) Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled. Noninferiority Trial Annals of Surgery 266(2):201–207
Ohue M, Iwasa S, Kanemitsu Y, Hamaguchi T, Shiozawa M, Ito M, Yasui M, Katayama H, Mizusawa J, Shimada Y, Colorectal Cancer Study Group/Japan Clinical Oncology Group (2017) A phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study). Jpn J Clin Oncol 47(1):84–87
Funding
This work was supported by 1•3•5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University (No. 2019HXFH031).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, X., Zhang, Y., Wei, M. et al. Letter to the editor regarding “Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?”. Int J Colorectal Dis 35, 2139–2140 (2020). https://doi.org/10.1007/s00384-020-03683-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-020-03683-y